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Objective. To investigate whether HLA-B27-mediated experimental spondyloarthritis (SpA) is associated with a common gut microbial signature, in order to identify potential drivers of pathogenesis.
Methods. The effects of HLA-B27 on 3 genetic backgrounds, dark agouti (DA), Lewis, and Fischer, were compared, using wild-type littermates and HLA-B7-transgenic Lewis rats as controls. Cecum and colon tissue specimens or contents were collected from the rats at 2, 3-4, and 6-8 months of age, and histologic analysis was performed to assess inflammation, RNA sequencing was used to determine gene expression differences, and 16S ribosomal RNA gene sequencing was used to determine microbiota differences.
Results. Both HLA-B27-transgenic Lewis rats and HLA-B27-transgenic Fischer rats developed gut inflammation, while DA rats were resistant to the effects of HLA-B27, and HLA-B7-transgenic rats were not affected. Immune dysregulation was similar in affected Lewis and Fischer rats and was dominated by activation of interleukin-23 (IL-23)/IL-17, interferon, tumor necrosis factor, and IL-1 cytokines and pathways in the colon and cecum, while DA rats exhibited low-level cytokine dysregulation without inflammation. Gut microbial changes in HLA-B27-transgenic rats were strikingly divergent on the 3 different host genetic backgrounds, including different patterns of dysbiosis in HLA-B27-transgenic Lewis and HLA-B27-transgenic Fischer rat strains, with some overlap. Interestingly, DA rats lacked segmented filamentous bacteria that promote CD4+ Th17 cell development, which may explain their resistance to disease.
Conclusion. The effects of HLA-B27 on gut microbiota and dysbiosis in SpA are highly dependent on the host genetic background and/or environment, despite convergence of dysregulated immune pathways. These results implicate an ecological model of dysbiosis, with the effects of multiple microbes contributing to the aberrant immune response, rather than a single or small number of microbes driving pathogenesis.
Spondyloarthritis (SpA) is an immune-mediated inflammatory disease encompassing several conditions that exhibit overlapping clinical features and genetic predisposition (1, 2) . Considerable evidence supports a link between gastrointestinal (GI) tract inflammation and the development of SpA (3) . Among patients with ankylosing spondylitis (AS), the prototype of SpA, 7% have coexisting inflammatory bowel disease (IBD), and another 60% have subclinical gut inflammation (4) . Similarly, arthritis develops in 10-50% of patients with IBD, and AS develops in nearly 10% of patients (5) .
Direct evidence showing that gut microbiota is critical for the development of SpA was derived from an animal model. Rats transgenic for HLA-B27, a major genetic risk factor for SpA, and human b 2 -microglobulin (hb 2 m), referred to hereafter as HLA-B27-transgenic, develop key features of human SpA when they are housed in a conventional or specific pathogen-free animal facility. In a germ-free environment, however, gut inflammation and joint inflammation are prevented (6, 7) . Recolonization of the gut with bacteria is sufficient to induce inflammatory gut and joint disease, implicating commensal bacteria in the development of HLA-B27-induced SpA (7) . More recently, our group demonstrated that expression of HLA-B27 and hb 2 m, as well as the non-disease-associated HLA-B7 allele, alters gut microbial communities in this animal model, providing compelling evidence that major histocompatibility complex class I proteins can shape the microbiome (8) . Alterations in gut microbiota in association with human SpA have also been observed in juvenile-onset disease (9), psoriatic arthritis (10), and AS (11) .
The mechanism or mechanisms by which HLA-B27 promotes the development of SpA remain unclear. Despite the central role of HLA-B27 in presenting peptides to cytotoxic CD8+ T lymphocytes, evidence showing that these cells drive disease in rats is lacking, and the SpA phenotype develops normally in Cd8a-deficient HLA-B27-transgenic animals (12) . In contrast, compelling evidence has implicated CD4+ T cells in the pathogenicity of inflammatory disease (13) , as demonstrated by activation of the interleukin-23 (IL-23)/IL-17 axis in both joint and gut inflammation in rats (14) as well as in humans with SpA (15) .
Aberrant features of HLA-B27, such as its tendency to misfold and dimerize, which can lead to endoplasmic reticulum stress and expression of aberrant cell surface complexes, have been implicated, and both misfolding and dimerization are linked to activation of the IL-23/IL-17 axis (16) . In addition, a growing appreciation for the contribution of endogenous microbiota to many disease states led Rosenbaum and Davey to hypothesize that an HLA-B27-induced change in gut microbiota may be a key intermediary in the development of SpA (17) . Recent evidence suggests that innate immune activation and Th17 cell expansion may precede the development of dysbiosis and gut inflammation in HLA-B27-transgenic rats (18) . Thus, it is important to understand how HLA-B27 shapes the gut microbiome.
Herein, we observed, quite unexpectedly, considerable differences in HLA-B27-mediated dysbiosis between 3 different rat strains. On the disease-permissive Lewis and Fischer backgrounds, different patterns of gut microbial dysbiosis were associated with common immune dysregulation reflecting activation of the IL-23/IL-17, interferon-c (IFNc), tumor necrosis factor (TNF), and IL-1 pathways in the cecum and colon. Our results indicate that the effects of HLA-B27 on gut microbiota diverge with different host genetic background and/or environment, despite similar mechanisms of immune dysregulation and inflammation. These results have important implications for understanding how HLA-B27 may shape the intestinal microbiome and promote disease in the diverse human population.
MATERIALS AND METHODS
Animals. All of the HLA-B27/hb 2 m-transgenic rats used in this study carried the same transgene locus , which contains genomic HLA-B27 and hb 2 m DNA (19) . The 33-3 locus was backcrossed from the original Fischer (F344) strain to the DA background (13) and then subsequently from the DA to the Lewis background for more than 10 generations (20) . HLA-B7-transgenic rats homozygous for the 120-4 transgene locus on the Lewis background were used (13) to ensure that expression of heavy chains in these rats was comparable with that in HLA-B27-transgenic rats (20) . While the HLA-B27-transgenic DA rats were resistant to disease, the HLA-B27-transgenic Lewis rats developed gut inflammation but not arthritis during the study period. HLA-B27-transgenic Fischer rats also developed gut inflammation and also more frequently developed arthritis (~30%), beginning at~3 months of age.
In the current study, both male and female transgenic Lewis, Fischer, and DA rats were used, with transgene-negative littermates (wild-type [WT]) used as controls. All rats were bred and housed at the National Institutes of Health (NIH), with the exception of HLA-B27-transgenic and WT Fischer rats, which were bred and housed at Oregon Health & Science University (OHSU). Animals were weaned at 21 days, and cohorts were randomly selected to undergo euthanasia at 2, 3-4, or 6-8 months of age. Fischer rats were housed after weaning according to their genotype, whereas the DA and Lewis rats were co-housed for a short period of time before being separated (according to weight limit requirements per cage). The DA and Lewis rat cohorts selected for euthanasia at 2 months of age were housed singly after weaning. All animals were maintained under specific pathogen-free conditions and fed Purina 5008 rat chow. Experiments were performed following approval by the Institutional Animal Care and Use Committees at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) or OHSU.
Histologic assessment. Hematoxylin and eosin-stained tissue sections from paraffin-embedded ileum, cecum, and colon samples were scored in a blinded manner by 2 independent observers, using an established scoring system (21) . Samples with initially discordant scores (scores differing by >1) were rerandomized and rescored to eliminate discrepancies.
Host transcriptome analysis. Tissue samples obtained from the cecum and colon were homogenized in TRIzol reagent (Invitrogen), and RNA was isolated using a standard phenol-chloroform extraction method. All samples used for RNA sequencing had an RNA integrity number of >8. Library preparation for RNA samples was performed according to the Illumina protocol. Single-end sequencing of 50 bases was performed using an Illumina HiSeq 2000 system, and raw reads were mapped to the rat rn5 genome, using TopHat version 2.0.8. Transcript expression levels (in reads per kilobase million [RPKM] ) and analysis of variance (ANOVA) were performed using Partek Genomics Suite 6.6. Differentially expressed genes were defined as those with a minimum 2-fold change (P < 0.05 and q < 0.2), with an RPKM value of >1 for various comparisons. Principal components analysis (PCA) was performed using Partek Genomics Suite 6.6, and Euler diagrams were constructed with eulerr (https://cran.r-projec t.org/package=eulerr) using RStudio 1.0.136.
Prediction of immune cell types. The Immunological Genome Project (ImmGen) function in ToppGene (22) was used 556 GILL ET AL to predict immune cell types, based on functional annotation of differentially expressed genes. Genes with increased expression (>2-fold; P < 0.05, q < 0.2) in HLA-B27-transgenic or HLA-B7-transgenic rats compared with WT controls on various backgrounds were used. We used ToppGene, which maps differentially expressed genes to multiple immune cell subtypes identified in ImmGen and then groups them into broader immune cell types. These are represented by multiple lines distinguished by color, with each line representing a P value (y-axis) based on the quality of the match to a specific immune cell subtype. Microbial community analysis. DNA was isolated from the ileum (mucosa), cecum (mucosa and lumen), and colon (lumen), using a Qiagen DNeasy kit. The 16S ribosomal RNA genes were amplified using 515-806 primers as specified by the Earth Microbiome Project (http://www.earthmicrobiome.org/), sequenced on an Illumina MiSeq system (23) , and processed in Qiita (www.qiita.ucsd.edu). Data were quality-filtered using QIIME (Quantitative Insights into Microbial Ecology) version 1.9.1, and taxa were identified and assigned to the species level (phylogenetic level 7). We compared the relative frequency of gut microbes in the ileum (mucosa), cecum (mucosa and lumen), and colon (lumen) at the species level (maximum >0.1%; P < 0.05, q < 0.1) and in the WT controls. Operational taxonomic units classified to the species level were used. To construct Euler diagrams, eulerr (https://cran.r-project.org/package=eulerr) was used in RStudio 1.0.136.
Statistical analysis. For RNA sequencing data, ANOVA was used to compare differences between group means of log 2 -transformed RPKM values (offset by 0.1). Using the Partek Genomics Suite, we performed false discovery rate (FDR) analysis to account for multiple tests (q < 0.2). For the microbiome analysis, nonparametric Wilcoxon signed rank tests using the FDR approach to correct for multiple comparisons were used to compare relative frequencies (P < 0.05, q < 0.1). Individual Wilcoxon tests were performed to calculate statistical significance between groups, using JMP version 12.2.0. RPKM counts for individual genes were assessed with 2-tailed t-tests, using GraphPad Prism 6.
RESULTS
Variable penetrance and severity of HLA-B27-induced gut inflammation. To determine the role of genetic background on HLA-B27-induced gut inflammation and dysbiosis, we compared the effects of the same transgene locus (33-3) that encodes HLA-B27 and hb 2 m, in DA, Lewis, and Fischer rats (13) . HLA-B7/hb 2 mtransgenic rats (120-4 transgene locus) were used as an HLA class I control for the Lewis background. The animals were weaned at 3 weeks of age and then randomized to undergo euthanasia at 2, 3-4, or 6-8 months of age. Samples were collected from the terminal ileum, cecum, and distal colon for histologic analysis, microbiome studies, and gene expression analysis ( Figure 1A and also Supplementary (21) . The lines were generated by regression analysis, and the shaded areas depict 95% confidence intervals (95% CIs). Rats with scores of >2.5 were considered abnormal. C, Correlation between cecum and colon histology scores. Each data point represents the score for an individual rat; shaded areas depict 95% CIs. WT = wild-type; M = months; rRNA = ribosomal RNA; QIIME = Quantitative Insights into Microbial Ecology; seq = sequence.
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Histology scores revealed that the presence and severity of gut inflammation are strongly dependent on background. DA rats were resistant to the effects of HLA-B27, while Lewis and Fischer rats developed inflammation in the cecum and colon, which was already apparent at 2 months of age ( Figure 1B) , while the ileum was spared (results not shown). At age 2-3 months, Fischer rats were affected more severely, although by 6 months of age cecum and colon histology scores were comparable between HLA-B27-transgenic Lewis and Fischer rats. HLA-B7 did not cause GI tract inflammation in Lewis rats, which is consistent with previous observations (13) . We did not observe sex differences in gut inflammation between HLA-B27-transgenic Lewis and HLA-B27-transgenic Fischer rats (data not shown). In affected rats, there was a strong correlation between cecum and colon histology scores ( Figure 1C) Figure 2A , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.40405/abstract). In contrast, samples from HLA-B7-transgenic Lewis and HLA-B27-transgenic DA rats that had normal histology scores clustered with their respective background controls. There was no clustering of samples according to sex (data not shown).
Next, we identified differentially expressed genes (HLA-B27-transgenic versus WT) in the cecum and colon of DA, Lewis, and Fischer rats (fold change >2 or <À2; P < 0.05, q < 0.2). Significantly overexpressed genes (Figure 2A ) or underexpressed genes (Supplementary Figure 2B) in the cecum and colon were more numerous in Fischer rats, followed by Lewis rats. Disease-resistant DA rats had relatively few differentially expressed genes, which was consistent with the normal histology scores. The vast majority of up-regulated genes on the Lewis (81%) and DA (93%) backgrounds overlapped with Fischer backgrounds, as shown in area-proportional Euler diagrams (Figure 2A) . In HLA-B7-transgenic rats, there were 38 and 45 differentially expressed genes in the cecum and colon, respectively, but there was minimal overlap with the effects of HLA-B27 on the DA, Lewis, Figure 2 . HLA-B27-associated gene expression in DA, Lewis, and Fischer rat cecum and colon. A, The numbers of differentially expressed genes (HLA-B27-transgenic versus wild-type [WT]) on DA, Lewis, and Fischer backgrounds in the cecum and colon are shown in Euler diagrams depicting overlaps and the lack of overlaps between backgrounds. Genes were selected based on a fold increase of >2, with P < 0.05 and q < 0.2. B, Differentially expressed genes in the cecum and colon of HLA-B27-transgenic Lewis and Fischer rats were identified by pathway analysis using ToppGene. Results for the cecum and colon were identical. The Euler diagram shows complete overlap of inflammatory pathways between Lewis and Fischer rats (P < 0.05). C, Temporal expression patterns of transcripts positively correlated (r > 0.6) with disease scores in the cecum and colon in DA, Lewis, and Fischer rats are shown. D, Expression of the selected individual genes in the cecum in DA, Lewis, and Fischer rats is shown. Individual genes represent key cytokines in the pathways shown in B. Shown are log 2 -transformed reads per kilobase million (RPKM) values for each gene. Bars show the mean AE SEM (n = 9-16 rats per group). * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.0001. IFNc = interferon-c; TNF = tumor necrosis factor; IL-17 = interleukin-17; TCR = T cell receptor; BCR = B cell receptor.
or Fischer backgrounds (results not shown). Pathway analysis of HLA-B27-associated up-regulated genes revealed inflammatory pathways such as IFNc, TNF, IL-23, IL-17, IL-12, Toll-like receptor, T cell receptor, and B cell receptor-mediated signaling as well as others, while the pathways identified by down-regulated genes revealed a loss of metabolism that included lipids and proteins, biologic oxidation, and digestion and absorption, with a huge overlap between HLA-B27-transgenic Lewis and Fischer rats ( Figure 2B and Supplementary Figure 2C, respectively) . In addition, the same pathways were identified in the cecum and colon.
To determine whether HLA-B27-associated pathways ( Figure 2B ) were correlated with disease severity, we independently identified genes that had increased expression and were most strongly correlated (r > 0.6) with histology scores in the cecum and colon across all genotypes and backgrounds ( Figure 1B) . The temporal pattern of expression of positively correlated genes is shown in Figure 2C , and that of negatively correlated genes is shown in Supplementary Figure 2D . As expected, there was an age-dependent increase in expression in HLA-B27-transgenic Lewis rats and consistently high expression in HLA-B27-transgenic Fischer rats, whereas expression levels in HLA-B7-transgenic Lewis rats were not different from those in control rats.
Pathway analysis of the genes positively correlated and those negatively correlated with the severity of inflammation in the cecum as well as the colon revealed considerable overlap with the pathways shown in Figure 2B and Supplementary Figure 2C , respectively. Interestingly, there was low-level up-regulation of a small subset of these genes in HLA-B27-transgenic DA rats ( Figure 2C ) despite normal histology scores. These differences were most pronounced at 2-3 months of age and were lost in older HLA-B27-transgenic DA rats. Expression of several of the cytokine genes driving these inflammatory pathways in the cecum and colon is shown in Figure 2D and Supplementary Figure 2E , respectively. The relative expression of these genes in HLA-B27-transgenic rats compared with that in their WT controls was consistent with differences in disease penetrance and severity between backgrounds ( Figure 1B) .
Using differentially expressed genes to predict increases in the number of immune cell types in transgenic compared with WT rats revealed strikingly similar profiles in the cecum and colon and also between HLA-B27-transgenic Lewis and Fischer rats (Supplementary Figure 3) .
Shared HLA-B27-induced inflammatory pathways contrast background-dependent dysbiosis. The striking overlap in dysregulated immune pathways associated with HLA-B27 in the Lewis and Fischer backgrounds suggested that there might be a core group of dysbiotic microbes. To evaluate this possibility, we determined the relative abundance of microbes at the species level in all tissue sites and rat strains. This evaluation revealed 90 microbes that were differentially abundant (HLA class I-transgenic versus WT) in at least 1 tissue location on at least 1 genetic background. Hierarchical clustering of these 90 microbes resulted in distinct groups based on tissue location and genetic background (Supplementary Figure 4 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/ art.40405/abstract). We did not observe sex-based differences in dysbiosis (data not shown).
The first hierarchal division in the dendrogram was driven by microbial differences between the large intestine (cecum and colon) and the ileum ( Supplementary Figure 4) . Unexpectedly, we observed several backgroundspecific differences in the effects of HLA-B27 in the cecum and colon (Figure 3 ). There were HLA-B27-associated increases in the abundance of Akkermansia and Bacteroides uniformis in Fischer rats, while these microbes were not significantly different in HLA-B27-transgenic Lewis or DA rats compared with their respective WT controls. There were also HLA-B27-associated increases in Roseburia and Anaerotruncu and a decrease in Coprococcus, which were limited to the Fischer background. In contrast, the frequency of f_Christenellaceae was decreased in the cecum mucosa in HLA-B27-transgenic Lewis rats but not in DA or Fischer rats. Furthermore, there were HLA-B27-associated decreases in the abundance of Mucispirillum schaedleri and an unknown species of genus, Mucispirillum, on the Lewis background, which were not seen in Fischer or DA rats. Lewis rats showed an HLA-B27-associated increase in Prevotella at multiple tissue sites (e.g., cecum and colon lumen), but an increase was not observed in HLA-B27-transgenic Fischer rats in the cecum lumen and in DA rats. In addition, there was an HLA-B27-associated increase in the frequency of an unclassified genus of f_Barnesiellaceae in cecum and colon fractions in Lewis rats and in cecal mucosa in DA rats but not Fischer rats. In the ileum of Lewis rats, there was an HLA-B27-associated increase in the frequency of HLA-B27 AND GUT MICROBIAL DYSBIOSISSutterella that was also observed in other tissue sites in Lewis rats and in the cecum fractions in DA rats, while it was not seen in Fischer rats (see Supplementary Figure 4 ). Statistically significant differences between these 90 microbes (q < 0.1) and an additional 20 microbes (q <0.2 but >0.1) and their phylogeny are shown in Supplementary  Tables 2 and 3 , respectively. These additional microbes were included, because many exploratory analyses such as ours use a q value of <0.2 as a selection criterion.
A comparison of differentially abundant (HLA-B27-transgenic versus WT) microbes at the species level in each background and each tissue site, using area-proportional Euler diagrams, is shown in Figure 4 . This demonstrated a lack of overlap in HLA-B27-associated differences between Lewis and Fischer backgrounds in the ileum and cecum mucosa and a small overlap in the cecum and colon lumen. Taken together, these results showed that there was a substantial effect of genetic background and/or environment on HLA-B27-associated differences in gut microbiota, although shared microbes were also apparent.
Absence of segmented filamentous bacteria in disease-resistant DA rats. A potentially important difference between backgrounds is the absence of Candidatus arthromitus in the DA rats, independent of HLA-B27. C arthromitus, more commonly known as segmented Figure 3 . Relative abundance of species-level microbes in cecum and colon samples from DA (D), Lewis (L), and Fischer (F) rats. The heatmap shows unsupervised hierarchical clustering of species-level microbes in HLA-B27/HLA-B7-transgenic rats compared with wild-type (WT) controls on DA, Lewis, and Fischer backgrounds. Samples from the ileum (mucosa), cecum (mucosa and lumen), and colon (lumen) were used. Microbes exhibiting differences in relative abundance, as calculated using a nonparametric Wilcoxon test for paired data (P < 0.05, q < 0.1) in at least 1 tissue type on at least 1 background, were used to construct the heatmap. Genera with a high relative abundance of ileum fractions are shown in Supplementary Figure 4 
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GILL ET AL filamentous bacteria (SFB), is a major constituent (although variable) in the ileum of both HLA-B27-transgenic and WT Lewis and Fischer rats ( Figure 5A ). SFB are known to attach to intestinal epithelial cells and potentiate induction of Th17 cells that play a key role in several inflammatory diseases (24) , including colitis (25, 26) , and thus their absence in DA rats could be responsible for resistance to HLA-B27-mediated disease on this background. It is also worth noting that the frequency of SFB was very low in HLA-B7-transgenic Lewis rats. In DA and HLA-B7-transgenic Lewis rats lacking SFB, 2 major contributors to this niche appeared to be f_Clostridiaceae (unknown genera) and Lactobacillus, respectively ( Figure 5B ). Background-dependent HLA-B27-induced microbial dysbiosis. To further assess the effects of HLA-B27 in disease-permissive backgrounds, we performed PCA based on the differential relative abundance of microbes in Lewis and Fischer rats transgenic for HLA-B27. This comparison revealed major differences between the Lewis and Fischer backgrounds ( Figure 6A ). However, within each background there was a clear distinction between HLA-B27-transgenic rats and WT controls. The lack of convergence of samples from HLA-B27-transgenic Lewis rats and HLA-B27-transgenic Fischer rats in the PCA suggested that HLA-B27 drives dysbiosis in a background-specific manner. Indeed, when we compared the effects of HLA-B27 on the 2 backgrounds, there was a paucity of core dysbiotic organisms ( Figure 6B ). To ensure that background-specific effects of HLA-B27 were not attributable to differences in disease severity, we selected samples from HLA-B27-transgenic rats (Lewis and Fischer) with similar histology scores (range 5-8) and reanalyzed them in comparison with their age-matched controls. This revealed slightly altered profiles in each background, but there was no increase in overlap (data not shown), confirming the background-dependence of HLA-B27-associated dysbiosis.
DISCUSSION
Host-microbe interactions play an important role in the development of many immune-mediated inflammatory diseases (27) . In SpA, this interaction ranges from the pathogenic gram-negative intracellular bacteria that trigger reactive arthritis in HLA-B27-positive individuals to gut commensal bacteria that are necessary for the development of experimental SpA in HLA-B27-transgenic rats (7) and possibly in humans. Although many additional genes contribute to the risk of SpA in humans, the prominent role of HLA-B27 has fueled the notion that it might promote SpA by altering gut microbiota (17) .
In the current study, we hypothesized that comparing gut microbiota in 3 distinct rat strains that differ with regard to disease penetrance and HLA-B27-mediated disease severity would facilitate the identification of common microbial signatures associated with experimental SpA. However, we observed that gut microbial changes associated with HLA-B27 were strikingly different between DA, Lewis, and Fischer rat strains, in which disease penetrance also differs. Therefore, to better understand microbial shifts in the context of inflammation (dysbiosis), we compared disease-susceptible Lewis and Fischer rat strains. This revealed persistent differences in microbiota between the strains, which were not due to differences in disease severity.
To ensure that the lack of overlap was not attributable to the conservative FDR value (q < 1), we performed the same analysis using a q value of <0.2 (Supplementary Tables 2 and 3, available com/doi/10.1002/art.40405/abstract). While this resulted in an increased number of overlapping and nonoverlapping microbes, the percentage of overlapping microbes remained unaltered. It should be noted that although WT rats of these 3 backgrounds exhibited considerable overlap of their gut microbiota, the relative abundance of these microbes differed substantially (for additional information, see Supplementary Figure 5 and Supplementary Table 4 ). The paucity of shared dysbiotic microbiota associated with HLA-B27 was in striking contrast to the common dysregulated immune pathways in Lewis and Fischer rat strains, characterized by prominent increases in IL-1, IL-23, IL-17, IFNc, and TNF cytokines and pathways. Taken together, our data indicate that background has a prominent effect on HLA-B27-induced microbial dysbiosis despite common immune dysregulation. Although arthritis is an important component of SpA, HLA-B27-transgenic Lewis rats infrequently exhibited arthritis prior to 6 months of age at our facility, thus precluding any relevant analysis. On the Fischer background, 32% of the HLA-B27-transgenic rats developed arthritis (mostly older animals). A comparison of the species-level gut microbiota in rats with arthritis and in agematched HLA-B27-transgenic rats without arthritis did not reveal any significant microbial differences. However, given the relatively small number of rats with arthritis, further studies will be needed before any conclusions can be drawn.
We have implied that the different effects of HLA-B27 on gut microbiota in Lewis and Fischer rats are primarily attributable to genetic background. However, it is important to note that the Fischer rat colony was maintained at OHSU, while all other rats were bred and housed at the NIH. Although all rats were maintained on a diet of the same commercially available rat chow, environmental differences are likely to alter microbial communities between Lewis and Fischer rats. However, an environmental contribution to differences between Lewis and Fischer strains does not alter the fact that dramatically different patterns of dysbiosis occur in the context of common immune dysregulation caused by HLA-B27. We have previously housed Fischer rats at the NIH and observed increased severity of gut inflammation in HLA-B27-transgenic rats at disease onset (based on the stool consistency), similar to what we report here for animals housed in 2 different facilities. This further supports an important role for genetic background in causing differences between Fischer and Lewis HLA-B27-transgenic rats.
Although changes in microbiota composition can cause (or be a response to) an immune stimulus, in reality they may be a combination of both factors and evolve rapidly, making it difficult to establish a temporal relationship (28) . Previous work in HLA-B27-transgenic Fischer rats revealed gut inflammation prior to microbial changes (18) , but that analysis was limited to select microbiota and thus did not rule out other earlier differences. In the current study, although we initially analyzed cohorts based on age, we eventually grouped together rats of all ages in order to simplify the analyses. However, our initial analysis showed immune dysregulation and microbial dysbiosis at the earliest time point in HLA-B27-transgenic Lewis and Fischer rats (data not shown), thus precluding any conclusions about cause and effect. Nevertheless, the results in DA rats underscore the fact that HLA-B27 can cause immune dysregulation (e.g., low-level increase in Il1a, Il1b, Tnf, and Il17a transcripts, with immune cell changes) without progression to a disease phenotype. These changes seen in young HLA-B27-transgenic DA rats were not sustained in older animals. This could be attributable to the lack of SFB in DA rats. SFB are required for Th17 cell development in several rodent strains (24) and thus may be critical in experimental SpA. These bacteria are known to colonize ileal epithelium shortly before weaning and are highly refractory to in vitro culturing (29) . It should be noted that HLA-B27-transgenic DA rats have been reported to develop severe gut inflammation and cachexia, which were not seen in WT rats when they were inadvertently exposed to an unknown infectious agent (13) . The episode was transient but nevertheless suggests that they are not completely resistant to the effects of HLA-B27.
It is clear from the current study and previous work (8) that HLA-B7 is associated with major shifts in gut microbial composition (Supplementary Table 2 , http:// onlinelibrary.wiley.com/doi/10.1002/art.40405/abstract). Herein, we document the absence of immune dysregulation in these animals, at the level of both individual cytokines and immune cell signatures, indicating that microbial differences are not sufficient to provoke an inflammatory response (8) and underscoring the unique effects of HLA-B27.
Because the majority of microbes associated with HLA-B27-induced disease differ between the Lewis and Fischer backgrounds, we considered that there might be important functional overlaps. Two prominent examples are HLA-B27-associated increases in Akkermansia muciniphila (p_Verrucomicrobia) in Fischer and Prevotella (p_Bacteroidetes) in Lewis strains. While they are phylogenetically diverse, both of these microbes disrupt mucosal homeostasis and have been linked to gut inflammation by disrupting mucosal homeostasis (9, 30) . Akkermansia exacerbates inflammation by degrading the mucous layer overlying gut epithelial cells, thereby weakening the protective barrier (31) . A muciniphila has been reported to be increased in a subset of patients with juvenile SpA (9) and exacerbated Salmonella-induced gut inflammation (31) . In contrast, a decrease in the abundance of A muciniphila has been linked to obesity in mouse models (32, 33) .
Our results suggest that mucus degradation by A muciniphila, along with dysregulated goblet cell production during inflammation, may be sufficient to bring lumenal bacteria closer to the gut epithelium and promote inflammation. Similarly, Prevotella has been implicated in dysbiosis due to NLRP6 deficiency (34) , colitis (30) , ankylosing spondylitis (35) , and psoriatic arthritis (10) . Prevotella encodes enzymes (e.g., superoxide reductase and phosphoadenosine phosphosulphate reductase), enabling it to resist host reactive oxygen species and invade epithelial cell crypts, most likely by outcompeting commensal organisms that normally maintain mucosal homeostasis (30) . Lipopolysaccharide (LPS) from A muciniphila has been shown to be more immunostimulatory than that from Prevotella (36), which may also explain the differences in disease severity between Fischer and Lewis backgrounds.
Although we highlighted a surprising lack of common dysbiotic microbes between different backgrounds, there were core similarities between HLA-B27-transgenic Lewis and Fischer rats, particularly in the lumen of the cecum and colon, which may play a role in disease development. This group includes short-chain fatty acid producers such as Clostridium and Coprobacillus, the relative abundance of which is increased, and Ruminococcus, the production of which is decreased (37). Short-chain fatty acids such as butyrate are important because they influence regulatory Tcell homeostasis (38) . In addition, colonic epithelial cells from germ-free mice exhibit a mitochondrial respiration deficit and enhanced autophagy as a consequence of reduced production of short-chain fatty acids (39) . Recent studies have shown an increase in the frequency of the short-chain fatty acid producer Ruminococcus gnavus (40) and the medium-chain fatty acid producer Dialister (41) in SpA. Because some short-chain fatty acid producers in HLA-B27-transgenic rats are increased while others are decreased, additional studies will be needed to determine the overall impact of these changes. Despite the phylogenetic differences in the HLA-B27-associated Lewis and Fischer microbiota, these nonoverlapping microbes may perturb common metabolic pathways, thus explaining shared immune dysregulation in these animals. Future studies using metagenomic sequencing along with metabolomic analysis will enable further characterization and provide functional relevance to these microbial changes.
Gut microbiota play an important role in the development of the host immune system, which in turn shapes the composition of gut microbiota (42, 43) . It is clear from observations in animal models that gut microbial communities co-evolve with their host and exhibit strong ecological interactions, varying according to the host genotype, diet, and colonization history (43) . Our results demonstrate that the effect of HLA-B27 on gut microbiota in experimental SpA is largely dependent on host genetics and environment. In addition, dysbiotic microbes contributing to HLA-B27-associated inflammation need not be linked taxonomically, but rather, similarities in their metabolic functions and/or gut microenvironment are key drivers of pathogenesis. In addition, HLA-B27-mediated disease in rats might depend on SFB, although this needs to be determined experimentally.
In summary, the results of gene expression analysis and microbial community profiling to characterize the effect of HLA-B27 on 3 different genetic backgrounds provide an unprecedented and comprehensive view of the complexity of microbial dysbiosis associated with common immune dysregulation and gut inflammation in SpA. Although we observed a common immune signature associated with gut inflammation, microbial dysbiosis was surprisingly different. The absolute dependence of this model on gut microbiota, together with the striking differences between host backgrounds, implicate an ecological model of dysbiosis in HLA-B27-induced experimental SpA in which the effects of multiple microbes contribute to the aberrant immune response, rather than a single or small number of microbial genera driving pathogenesis. Given that recombinant inbred animal strains are analogous to unrelated human individuals, our results suggest that characterization of functionally similar dysbiotic microbial communities may be critical to revealing underlying mechanisms of host-microbe interactions contributing to SpA.
